vs
Side-by-side financial comparison of PARK AEROSPACE CORP (PKE) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $17.3M, roughly 1.1× PARK AEROSPACE CORP). PARK AEROSPACE CORP runs the higher net margin — 17.0% vs -3.0%, a 20.0% gap on every dollar of revenue. On growth, PARK AEROSPACE CORP posted the faster year-over-year revenue change (20.3% vs -25.6%). PARK AEROSPACE CORP produced more free cash flow last quarter ($4.3M vs $2.2M). Over the past eight quarters, PARK AEROSPACE CORP's revenue compounded faster (3.0% CAGR vs -10.1%).
Park Electrochemical Corp, now called the Park Aerospace Corp, is a Melville, New York-based materials manufacturer for the telecommunications, Internet infrastructure, high-end computing, and aerospace industries. It produces high-technology digital and radio frequency(RF)/microwave printed circuit material products, composite materials. Its printed circuit materials are used for complex multilayer printed circuit boards and other electronic interconnection systems, such as multilayer back-p...
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
PKE vs RMTI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $18.3M |
| Net Profit | $3.0M | $-554.0K |
| Gross Margin | 34.1% | 21.1% |
| Operating Margin | 21.0% | -2.2% |
| Net Margin | 17.0% | -3.0% |
| Revenue YoY | 20.3% | -25.6% |
| Net Profit YoY | 87.1% | 26.7% |
| EPS (diluted) | $0.15 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.3M | $18.3M | ||
| Q3 25 | $16.4M | $15.9M | ||
| Q2 25 | $15.4M | $16.1M | ||
| Q1 25 | $16.9M | $18.9M | ||
| Q4 24 | $14.4M | $24.7M | ||
| Q3 24 | $16.7M | $28.3M | ||
| Q2 24 | $14.0M | $25.8M | ||
| Q1 24 | $16.3M | $22.7M |
| Q4 25 | $3.0M | $-554.0K | ||
| Q3 25 | $2.4M | $-1.8M | ||
| Q2 25 | $2.1M | $-1.5M | ||
| Q1 25 | $1.2M | $-1.5M | ||
| Q4 24 | $1.6M | $-756.0K | ||
| Q3 24 | $2.1M | $1.7M | ||
| Q2 24 | $993.0K | $343.0K | ||
| Q1 24 | $2.7M | $-1.7M |
| Q4 25 | 34.1% | 21.1% | ||
| Q3 25 | 31.2% | 14.3% | ||
| Q2 25 | 30.6% | 15.6% | ||
| Q1 25 | 29.3% | 16.1% | ||
| Q4 24 | 26.6% | 14.7% | ||
| Q3 24 | 28.5% | 22.0% | ||
| Q2 24 | 29.3% | 17.6% | ||
| Q1 24 | 27.3% | 13.5% |
| Q4 25 | 21.0% | -2.2% | ||
| Q3 25 | 17.4% | -9.9% | ||
| Q2 25 | 15.7% | -8.4% | ||
| Q1 25 | 16.8% | -7.2% | ||
| Q4 24 | 12.8% | -2.1% | ||
| Q3 24 | 15.7% | 6.8% | ||
| Q2 24 | 14.9% | 2.0% | ||
| Q1 24 | 15.7% | -5.8% |
| Q4 25 | 17.0% | -3.0% | ||
| Q3 25 | 14.7% | -11.0% | ||
| Q2 25 | 13.5% | -9.3% | ||
| Q1 25 | 7.4% | -8.0% | ||
| Q4 24 | 10.9% | -3.1% | ||
| Q3 24 | 12.4% | 5.9% | ||
| Q2 24 | 7.1% | 1.3% | ||
| Q1 24 | 16.3% | -7.6% |
| Q4 25 | $0.15 | $-0.01 | ||
| Q3 25 | $0.12 | $-0.05 | ||
| Q2 25 | $0.10 | $-0.05 | ||
| Q1 25 | $0.06 | $-0.04 | ||
| Q4 24 | $0.08 | $-0.02 | ||
| Q3 24 | $0.10 | $0.04 | ||
| Q2 24 | $0.05 | $0.01 | ||
| Q1 24 | $0.13 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $63.6M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.6M | $37.0M |
| Total Assets | $118.1M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.6M | $10.7M | ||
| Q3 25 | $61.6M | $13.6M | ||
| Q2 25 | $65.6M | $12.5M | ||
| Q1 25 | $68.8M | $11.4M | ||
| Q4 24 | $70.0M | $15.7M | ||
| Q3 24 | $72.0M | $12.3M | ||
| Q2 24 | $74.4M | $11.9M | ||
| Q1 24 | $77.2M | $6.6M |
| Q4 25 | $106.6M | $37.0M | ||
| Q3 25 | $105.8M | $37.0M | ||
| Q2 25 | $105.0M | $30.4M | ||
| Q1 25 | $107.2M | $31.5M | ||
| Q4 24 | $107.4M | $32.6M | ||
| Q3 24 | $110.3M | $29.1M | ||
| Q2 24 | $111.7M | $23.5M | ||
| Q1 24 | $112.9M | $20.6M |
| Q4 25 | $118.1M | $57.1M | ||
| Q3 25 | $116.4M | $57.5M | ||
| Q2 25 | $120.7M | $52.6M | ||
| Q1 25 | $122.1M | $54.0M | ||
| Q4 24 | $124.2M | $59.2M | ||
| Q3 24 | $125.1M | $57.1M | ||
| Q2 24 | $129.4M | $53.0M | ||
| Q1 24 | $132.3M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $5.1M | $2.3M |
| Free Cash FlowOCF − Capex | $4.3M | $2.2M |
| FCF MarginFCF / Revenue | 24.6% | 12.0% |
| Capex IntensityCapex / Revenue | 4.8% | 0.5% |
| Cash ConversionOCF / Net Profit | 1.73× | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.4M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $2.3M | ||
| Q3 25 | $-2.1M | $-1.3M | ||
| Q2 25 | $1.6M | $1.8M | ||
| Q1 25 | $969.0K | $-3.5M | ||
| Q4 24 | $2.7M | $865.0K | ||
| Q3 24 | $1.4M | $4.3M | ||
| Q2 24 | $-423.0K | $1.4M | ||
| Q1 24 | $5.3M | $-2.4M |
| Q4 25 | $4.3M | $2.2M | ||
| Q3 25 | $-2.3M | $-1.5M | ||
| Q2 25 | $1.1M | $1.7M | ||
| Q1 25 | $338.0K | $-3.5M | ||
| Q4 24 | $2.7M | $470.0K | ||
| Q3 24 | $1.3M | $4.1M | ||
| Q2 24 | $-435.0K | $1.2M | ||
| Q1 24 | $5.1M | $-2.5M |
| Q4 25 | 24.6% | 12.0% | ||
| Q3 25 | -14.0% | -9.6% | ||
| Q2 25 | 7.2% | 10.5% | ||
| Q1 25 | 2.0% | -18.8% | ||
| Q4 24 | 18.6% | 1.9% | ||
| Q3 24 | 7.5% | 14.4% | ||
| Q2 24 | -3.1% | 4.5% | ||
| Q1 24 | 31.4% | -11.1% |
| Q4 25 | 4.8% | 0.5% | ||
| Q3 25 | 1.1% | 1.4% | ||
| Q2 25 | 3.1% | 1.0% | ||
| Q1 25 | 3.7% | 0.3% | ||
| Q4 24 | 0.4% | 1.6% | ||
| Q3 24 | 1.2% | 0.7% | ||
| Q2 24 | 0.1% | 1.1% | ||
| Q1 24 | 1.0% | 0.6% |
| Q4 25 | 1.73× | — | ||
| Q3 25 | -0.88× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.78× | — | ||
| Q4 24 | 1.73× | — | ||
| Q3 24 | 0.70× | 2.57× | ||
| Q2 24 | -0.43× | 4.20× | ||
| Q1 24 | 1.98× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PKE
| North America | $16.8M | 97% |
| Other | $546.0K | 3% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
